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Abstract Patients presenting with functional somatic
syndrome (FSS) are common, and the symptoms are
persistent and difﬁcult to treat for doctors and costly for
society. The aim of this study was to clarify the com-
mon pathophysiology of FSS, especially the relationship
between hypothalamic-pituitary-adrenal (HPA) axis func-
tion and psychological characteristics of patients with FSS.
The subjects were 45 patients with FSS and 29 healthy
controls. Salivary free cortisol was measured in the morn-
ing, and psychological tests examining depression, anxiety
and quality of life (QOL) were performed on the same day.
In patients with FSS, depressive scores showed a signiﬁcant
negative correlation with salivary free cortisol in the
morning, although in healthy controls, cortisol showed a
signiﬁcant positive correlation with depressive scores. In
addition, the correlation between other psychological test
scores and cortisol secretion in patients with FSS contrasted
with that of controls. The relationship between cortisol and
depression, anxiety or QOL, suggests that the HPA axis of
patients with FSS is dysfunctional and does not function
properly when patients with FSS are under stress. This
dysfunction may explain the pathology of medically unex-
plained persistent symptoms of patients with FSS.
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Introduction
Functional somatic syndrome (FSS) is a group of syn-
dromes with medically unknown origins (Wessely et al.
1999; Kirmayer and Robbins 1991; Barsky and Borus
1999). FSS is common worldwide and is observed in most
areas of medicine (Henningsen et al. 2007). FSS is a
serious problem because the patients are often difﬁcult to
treat, and the treatments are costly for society (Kellner
1985; Peveler et al. 1997; Barsky and Borus 1999; Wessely
et al. 1999; Reid et al. 2002; Ring et al. 2004; Barsky et al.
2005; Salmon et al. 2006). FSS is characterized more by
symptoms, suffering and disability, than by disease-spe-
ciﬁc, demonstrable abnormalities of structure or function
(Barsky and Borus 1999). FSS is heterogeneous syndrome,
but the similarities outweigh the differences (Wessely et al.
1999; Nimnuan et al. 2001). Consequently the common
pathophysiology of FSS remains to be clariﬁed.
Previously, we examined the responses of the autonomic
nervous system to acute stress in patients with FSS using the
psychophysiological stress proﬁling (PSP) test (Kanbara
et al. 2004, 2005). Patients with FSS were hypo-reactive in
the psychophysiological acute stress response compared
with healthy controls. In addition, we reported two sub-
groups among patients with FSS that were identiﬁable
based on autonomic lability (i.e. low- and high-lability) and
independent of the symptoms or diagnostic category
(Kanbara et al. 2007).
In general, stress increases cortisol secretion through
the hypothalamic-pituitary-adrenal (HPA) axis. However,
chronically stressed (Schlotz et al. 2004; Ockenfels et al.
1995;W u ¨st et al. 2000) and burned out (Pruessner et al.
1999) people, even though they do not require medical
care, show lower salivary cortisol levels in the morning.
HPA axis function in patients with FSS may show either
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Geiss et al. 1997; Rief et al. 1998; Rief and Auer 2000)o r
hypo-reactive (Roberts et al. 2004; Jerjes et al. 2007;
Bo ¨hmelt et al. 2005) patterns. These reports suggest a
relationship between stress and cortisol secretion, although
the relationship may not be simple higher or lower levels
than controls.
Patients with FSS are under stress chronically because
of medically unexplained symptoms, and are signiﬁcantly
more depressed than patients with known organic pathol-
ogy (Henningsen et al. 2003). Patients with FSS show
dysfunction in autonomic nervous system response
(Kanbara et al. 2004, 2005), and if patients with FSS have
HPA axis dysfunction, they may show a different cortisol
secretion pattern from controls depending on the degree of
the stress or exhaustion. In this study we examined the
relationship between HPA axis function and the psycho-
logical characteristics of patients with FSS. Our hypothesis
was that this relationship may be different in patients with
FSS compared with that of healthy controls. In particular, a
higher degree of depression, which may be related to
exhaustion (Kopp et al. 1998; Fuhrer and Wessely 1995),
would be associated with a decrease in morning free cor-
tisol levels in patients with FSS.
Methods
Subjects
The subjects were 45 patients (28 females and 17 males: age
range = 16–80 years; mean ± standard deviation (SD) =
42.00 ± 15.68 years) who were diagnosed with FSS.
This study was conducted at the Department of Psy-
chosomatic Medicine of Kansai Medical University Hos-
pital in Osaka, Japan between August 2006 and March
2008. Patients deemed to beneﬁt from psychophysiological
assessment by the attending physicians and who had
undergone PSP tests were included in the study. Patients
who were unable to supply a saliva sample were excluded.
A total of 67 patients were included in the study. All
patients participating in the study provided written informed
consent.
To deﬁne FSS, Wessely emphasized the characteristics
of ‘‘medically unexplained’’ symptoms (Wessely et al.
1999). On the other hand, the deﬁnition provided Barsky
and Borus (1999), ‘‘Functional somatic syndrome refers to
several related syndromes that are characterized more by
symptoms, suffering and disability than by disease-speciﬁc,
demonstrable abnormalities of structure or function’’, may
be more applicable. Based on this deﬁnition, we established
the diagnostic criteria for using in our study (Kanbara et al.
2007). Patients were diagnosed as having FSS if the
following three conditions were fulﬁlled: (1) the chief
complaints were somatic symptoms that could not be
explained medically or by a psychiatric disorder; (2) the
subjective symptom rating score based on a visual analogue
scale (VAS) was[3/10, and the duration of the symptoms
was more than 6 months; and (3) the patient had disabilities
in social or daily activities due to the symptoms. According
to these conditions, 20 patients were excluded from the
study (because of FSS clitella (1), n = 10; VAS scale score,
n = 2; and\6 month duration of symptoms, n = 8). One
patient was excluded because of the possibility that he had
Cushing syndrome, and another patient was excluded
because he could not provide a saliva sample within 55 min
after waking up [the morning salivary cortisol morning
responses at 27 ± 38 min after waking were assessed, as
described by Yehuda et al. (2003)]. Finally, 45 patients
were included for the analyses in this study.
The diagnoses of the 45 patients were functional dys-
pepsia (n = 6), irritable bowel syndrome (n = 3), ﬁbro-
myalgia (n = 6), chronic fatigue syndrome (n = 2),
chronic pain (musculoskeletal symptoms; n = 11), head-
ache (tension-type or mixed-type; n = 6), other functional
gastrointestinal disorder (n = 3), and somatoform auto-
nomic dysfunction (n = 8). Diagnoses were made by the
attending physicians of the patients according to each cri-
terion of the disease. Functional dyspepsia and irritable
bowel syndrome were diagnosed by the ROME III (Tack
et al. 2006; Longstreth et al. 2006), ﬁbromyalgia was
diagnosed by the American College of Rheumatology 1990
Criteria (Wolfe et al. 1990), chronic fatigue syndrome was
diagnosed by the criteria of the International Chronic
Fatigue Syndrome Study Group (Fukuda et al. 1994),
chronic pain and somatoform autonomic dysfunction was
diagnosed by the International Statistical Classiﬁcation of
Disease and Related Health Problems Tenth Revision
(World Health Organization 1992a, b), and headache was
diagnosed by the International Classiﬁcation of Headache
Disorders 2nd Edition (Subcommittee of International
Headache Society 2004). Patients with disease of HPA axis
dysfunction were also excluded by the attending physicians.
Medication changes were limited as much as possible
prior to the examination. There were 28 patients with FSS
who took medication prior to examination. These medi-
cations included benzodiazepines (n = 18), antidepressants
(n = 18), and other general medications (n = 21). There
were no signiﬁcant differences in salivary free cortisol
levels in the morning between patients with FSS who did or
did not take benzodiazepines (t =- 0.453, p = 0.653),
antidepressants (t =- 1.757, p = 0.091), and general
medications (t =- 0.617, p = 0.541).
Ten patients with FSS were smokers and three patients
habitually consumed alcohol. There were no signiﬁcant
differences in salivary free cortisol levels in the morning
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or habitual drinkers and non-drinkers (t = 0.328, p =
0.771) in the patient with FSS group. All subjects were
advised to abstain from caffeine and alcohol intake the
night before the examination and to refrain from strenuous
exercise 1 day prior to the examinations.
Twenty-nine healthy subjects (15 female and 14 males;
age range 21–64 years; mean ± SD = 39.6 ± 8.4 years)
served as controls. They were recruited through public
announcement, and individuals receiving regular medical
care or had somatic symptoms more than once a week
were excluded. Subjects were paid $ 50 each for their
participation.
There were no signiﬁcant differences between the FSS
and control groups with respect to age (Mann–Whitney U
test; p = 0.877), male/female ratio (v
2 = 1.398, p =
0.173), women’s menstrual cycle (estrogenic phase, pro-
gestational phase, bleeding phase, or post menopause)
(v
2 = 3.386, p = 0.495), and post-awaking time (t =
1.723, p = 0.089). The study was approved by the ethical
committee of Kansai Medical University.
Measurement of Salivary Cortisol
Salivary cortisol was measured in the morning and PSP
was examined on the same day. Measurement of salivary
cortisol performed several times after waking is ideal for
the evaluation of HPA axis function (Edwards et al. 2001;
Kirschbaum and Hellhammer 1994, 1989; Hofman 2001;
Pruessner et al. 1997). However, since our subjects were
symptomatic, sampling was only performed only once at
30 min after waking, to minimize the burden on the sub-
jects. Yehuda et al. (2003) noted that a single salivary
sample taken at wake-up was a good indicator of overall
cortisol production. Subjects were advised, by written and
oral instructions, to refrain from eating or brushing their
teeth prior to saliva sampling. Saliva was collected using
Salivette sampling devices (Sarstedt, Germany). Saliva
samples were gathered at the time of PSP examination,
centrifuged, and then stored at -20C until assay. Salivary
cortisol levels in samples were measured by SRL, Inc.
Questionnaire Measures
The beck depression inventory II (BDI-II; Beck et al. 1996)
andstate-traitanxietyinventory(STAI)formX(Spielberger
1966)wereadministeredtoevaluatedepressionandanxiety,
both of which are associated with FSS (Henningsen et al.
2003). The reliability and validity of the Japanese version of
the both tests were supported previously (Kojima et al.
2002; Nakazato and Mizuguchi 1982). The proﬁle of mood
state (POMS; McNair et al. 1992) was used to evaluate the
temporary mood. The POMS, a 65-item scale, assesses six
affective mood dimensions. The subscales consist of
tension-anxiety (TA), depression-dejection (D; depressive
mood or discouragement), anger-hostility (A; irritation,
fury, and aggression), vigor-activity (V; activity, liveliness,
and happiness), fatigue-inertia (F; remaining inactive), and
confusion-bewilderment (C). The reliability and validity of
the Japanese edition of POMS was conﬁrmed previously
(Yokoyamaetal.1990).PatientswithFSSareunderchronic
stress, so it is important to check their actual daily life
condition. The OMS 8-item short-form health survey (SF-8;
Fukuhara and Suzukamo 2004) was employed to evaluate
the physical and emotional quality of life (QOL).
Statistical Analysis
T-test, two-way factorial analysis of covariance (ANOVA)
without replication and Mann–Whitney test were used to
compare the salivary free cortisol in the morning and
psychological test results in the FSS and control groups.
The relationship between salivary free cortisol in the
morning and psychological test results was analyzed by
Pearson ﬁrst-order correlation and multivariate regression
analysis using stepwise methods. Statistical analyses were
performed using SPSS 11.5 J statistical software for Win-
dows
TM (SPSS Inc., Chicago, IL). The two tailed a-level
was ﬁxed at 0.05.
Results
Table 1 shows the psychological characteristics of the FSS
group and the healthy control group. In patients with FSS,
the QOL scores and POMS-V were signiﬁcantly lower and
all the other psychological test scores were signiﬁcantly
higher (POMS-A was higher but not signiﬁcantly) than
those in healthy controls. Mean free cortisol in the morning
did not differ signiﬁcantly between the FSS group and
control group. There were no gender differences between
female and male in cortisol levels in both the FSS and
control group as shown by two-way factorial ANOVA
without replication (patients and controls, F(1, 70) = 0.73,
p = 0.40; female and male, F(1, 70) = 0.00, p = 0.97;
interaction, F(1, 70) = 1.15, p = 0.29).
Table 2 and Fig. 1 show the relationship between sali-
vary free cortisol in the morning and psychological test
scores. The relationship showed a contrasting tendency
between patients with FSS and controls. In the FSS group,
the BDI-II (Pearson correlation coefﬁcient (CC) =- 0.37,
p = 0.013), POMS-TA (CC =- 0.33, p = 0.025), POMS-
D (CC =- 0.44, p = 0.002), POMS-A (CC =- 0.39,
p = 0.008), POMS-F (CC =- 0.35, p = 0.020) and
POMS-C (CC =- 0.36, p = 0.014) scores showed a
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123signiﬁcant negative correlation with salivary free cortisol
in the morning, and the SF-8 mental component score
(MCS) of the QOL (CC =- 0.30, p = 0.044) score was
positively correlated. In the control group, STAI trait-anxiety
(CC = 0.62, p = 0.000), STAI state-anxiety (CC = 0.49,
p = 0.008), POMS-D (CC = 0.53, p = 0.003), POMS-F
(CC = 0.39, p = 0.038) and POMS-C (CC = 0.42, p =
0.025) were correlated signiﬁcantly with salivary free
cortisol in the morning, and POMS-V (CC =- 0.37, p =
0.047) and MCS (CC =- 0.40, p = 0.033) showed a
signiﬁcant negative correlation.
Table 3 shows the results of multivariate regression
analyses using stepwise methods. In patients with FSS,
POMS-D (p B 0.01) and the FS-8 physical component
score (PCS; p = 0.023) showed a signiﬁcant association
with salivary free cortisol in the morning. In healthy con-
trols, STAI trait anxiety (p B 0.01) was most associated
with salivary free cortisol levels in the morning.
Table 1 Characteristics of the FSS group and control group
Means (SD)\range[ p Values
FSS (n= 45) Control (n= 29)
Salivary free cortisol in the morning (nM/L) 17.69 (7.16) \1.66–29.26[ 19.40 (7.46) \4.42–34.78[ 0.334
Beck depression inventory II (BDI-II) 20.53 (11.72) \1–47[ 4.83 (6.43) \0–23[ 0.000**
State-trait anxiety inventory (STAI)
Trait anxiety 55.38 (11.83) \25–72[ 39.03 (8.98) \28–65[ 0.000**
State anxiety 51.13 (11.22) \31–74[ 39.97 (6.972) \25–57[ 0.000**
Proﬁle of mood state (POMS)
Tension-anxiety 55.73 (11.89) \33–81[ 42.79 (6.22) \33–58[ 0.000**
Depression 58.20 (11.58) \40–85[ 44.93 (5.28) \40–62[ 0.000**
Anger-hostility 50.71 (10.89) \37–81[ 47.76 (6.56) \38–61[ 0.124
Vigor 39.29 (8.46) \27–59[ 54.86 (8.46) \41–68[ 0.000**
Fatigue 55.89 (10.66) \35–75[ 45.52 (7.23) \35–66[ 0.000**
Confusion 57.07 (12.63) \34–85[ 43.07 (6.04) \34–55[ 0.000**
OMS 8-item short-form health survey (SF-8)
Physical component score (PCM) 35.63 (9.15) \16.74–58.83[ 51.59 (3.85) \43.74–58.69[ 0.000**
Mental component score (MCS) 38.15 (8.34) \20.19–55.39[ 49.42 (5.47) \36.55–56.72[ 0.000**
** p\0.01
Table 2 Correlation between
salivary free cortisol in the
morning and psychological tests
** p\0.01; * p\0.05
FSS group (n = 45) Control group (n = 29)
Correlation p Values Correlation p Values
Beck depression inventory II (BDI-II) -0.37 0.013* 0.33 0.810
State-trait anxiety inventory (STAI)
Trait anxiety -0.25 0.093 0.62 0.000**
State anxiety -0.16 0.286 0.49 0.008**
Proﬁle of mood state (POMS)
Tension-anxiety -0.33 0.025* 0.31 0.101
Depression -0.44 0.002** 0.53 0.003**
Anger-hostility -0.39 0.008** 0.20 0.288
Vigor 0.16 0.299 -0.37 0.047*
Fatigue -0.35 0.020* 0.39 0.038*
Confusion -0.36 0.014* 0.42 0.025*
OMS 8-item short-form health survey (SF 8)
Physical component score (PCS) -0.24 0.116 -0.18 0.340
Mental component score (MCS) 0.30 0.044* -0.40 0.033*
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123There were no signiﬁcant correlations between the
duration of symptoms and salivary free cortisol in the
morning in patients with FSS (min. 6 month, max.
480 month, mean 73.82 month, SD 97.41, Spearman’s
correlation 0.089, p values 0.562).
Discussion
The relationship between salivary free cortisol in the
morning and the psychological test scores differed between
patients with FSS and healthy controls (Fig. 1). In patients
with FSS, the HPA axis was hyper-functional when the
depressive mood state was not very high, while the HPA
axis was hypo-functional when the depressive state was
severe. These ﬁndings suggest that patients with FSS have
a dysfunctional HPA axis, and their cortisol secretion does
not function properly when patients with FSS are under
stress. In this study, patients with FSS showed medically
unexplained symptoms and were under prolonged stress.
These characteristics may lead to exhaustion, according to
the general adaptation theory of Hans Selye (1956). In our
previous study, we observed psychophysiological parame-
ters related to autonomic nervous function that were hypo-
reactive to mental work stress in patients with FSS
(Kanbara et al. 2004, 2005), possibly because the patients
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Fig. 1 The relationship between salivary free cortisol in the morning
and psychological test scores. j (black lines), FSS; (gray lines),
Control. Solid lines are statistically signiﬁcantly correlated (positively
or negatively) regression lines. Dotted lines are the other regression
lines. The relationship showed a contrasting tendency between
patients with FSS and controls. In the relationship between cortisol
and the proﬁle of mood state (POMS) depression, fatigue and mental
component score (MCS) of an 8-item short-form health survey (SF-8),
the regression lines of the FSS group and the control group were
crossed, and both were correlated signiﬁcantly with cortisol. In the
relationship between cortisol and the beck depression inventory II
(BDI-II) and state-trait anxiety inventory (STAI), the FSS group and
the control group show a contrasting correlation
Table 3 Multiple linear regression analysis for salivary free cortisol in the morning
B Standard error 95% conﬁdence interval Standardizes beta tp Values
FSS group (n = 45)
(Constant) 43.895 6.463 30.853 to 56.937 6.792 \0.01
**
POMS-depression -0.302 0.081 -0.466 to -0.138 -0.448 -3.714 \0.01
**
SF-8 PCS -0.242 0.103 -0.450 to -0.035 -0.31 -2.358 0.023
*
Control group (n = 29)
(Constant) -0.605 5.033 -10.932 to 9.722 -0.120 0.905
STAI-trait anxiety 0.512 0.126 -0.254 to 0.770 0.617 4.074 \0.01
**
POMS proﬁle of mood state; SF 8 OMS 8-item short-form health survey; PCS physical component score; STAI state-trait anxiety inventory
** p\0.01; * p\0.05
Appl Psychophysiol Biofeedback (2009) 34:291–298 295
123had reached a stage of exhaustion. The HPA axis dys-
function and other dysfunctions may be characteristics of
patients with FSS. The patients were unable to react
properly to the stressor, which may reﬂect their medically
unexplained symptoms.
In healthy controls, cortisol levels correlated positively
with depressive mood (POMS-D). The reason that cortisol
and BDI-II did not correlate in healthy controls was because
12 of the controls subjects (40%) had a score of 0. There-
fore, the relationship between cortisol and depression scores
in FSS showed a tendency contrary to that of controls.
According to the results of multivariate regression
analyses in patients with FSS, the temporally depressive
mood showed the strongest correlation with salivary cor-
tisol levels in the morning. Patients with FSS suffer from
unexplained physical symptoms, so it is interesting that
there was a meaningful relationship between a physically
low QOL (PCS) and HPA axis function. Furthermore, both
depression and PCS may be related to exhaustion.
The negative correlation between the depressive state
and salivary free cortisol in the morning was characteristic
of patients with FSS, and not characteristic of simply
depressed individuals. Parker et al. (2003) reported theoc-
currence of hypercortisolism in cases of major depression.
Maes et al. (1986) reported that in 100 patients with minor
and major depression, the serum cortisol levels were cor-
related with Hamilton Depression Rate Scale scores, and
cortisol levels were higher in patients with major depres-
sion than in those with minor depression. Other studies
have shown that the morning free cortisol in depressed
patients was higher than in controls (Yehuda et al. 1996;
von Zerssen et al. 1987). In healthy young men, the
morning free cortisol was reported to be increased in more
depressive individuals (Pruessner et al. 2003).
One of the limitations of the present study is that some
of the patients had multiple diagnoses, since FSS is a
diverse syndrome. In addition, we could not ensure uniform
sampling times, medication use, or menstruation cycle
characteristics, any of which may have affected the data,
because the subjects were experiencing symptoms that
required urgent medical treatment.
Future studies are planned, with attention to the rela-
tionship between depressive mood and salivary free corti-
sol in the morning, that will examine the existence some
subgroups in FSS.
Conclusion
The relationship between morning cortisol secretion and
psychological test scores were different between patients
with FSS and healthy controls. In patients with FSS, the
HPA axis was hyper-functional when the depressive mood
state was not very high and HPA axis was hypo-functional
when the depressive state was severe. These ﬁndings sug-
gest that patients with FSS, who were under prolonged
stress with medically unexplained symptoms, have a dys-
functional HPA axis, which may be the pathology of their
persistent symptoms.
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